2025-10-23 - Analysis Report
Okay, here's an analysis of UnitedHealth Group (UNH) based on the provided data, formatted as requested.

## UnitedHealth Group (UNH) Analysis

UnitedHealth Group Inc. is a diversified healthcare company providing a wide range of products and services.

### 1. Performance vs. S&P 500 (VOO)

*   **UNH Cumulative Return:** -16.65%
*   **VOO Cumulative Return:** 99.09%
*   **Absolute Divergence:** -114.1
*   **Divergence Range:** Max: 36.3, Min: -130.7
*   **Relative Divergence:** 9.9

**Analysis:** UNH has significantly underperformed the S&P 500 (VOO) over the analyzed period, with a substantial negative divergence. The relative divergence of 9.9 indicates that UNH's performance is near the bottom of its historical divergence range compared to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B)  |
| ---------- | ------ | ------ | ------- | ------ | ------- |
| 2015-2017  | 58.0%  | 66.4%  | 30.0%   | 0.1    | 197.5   |
| 2016-2018  | 41.0%  | 70.4%  | 26.0%   | 0.1    | 223.2   |
| 2017-2019  | 36.0%  | 73.8%  | 14.0%   | 0.2    | 263.4   |
| 2018-2020  | -43.0% | 81.2%  | -67.0%  | 0.5    | 314.2   |
| 2019-2021  | 16.0%  | 81.2%  | -30.0%  | 1.5    | 449.9   |
| 2020-2022  | -1.0%  | 81.2%  | 0.0%    | 1.5    | 475.1   |
| 2021-2023  | 24.0%  | 80.8%  | 23.0%   | 0.4    | 471.8   |
| 2022-2024  | -27.0% | 78.8%  | -47.0%  | 0.3    | 453.3   |
| 2023-2025  | -59.0% | 78.8%  | -123.0% | 1.2    | 327.4   |

**Analysis:**

*   **CAGR Trend:** Shows significant volatility. High growth in earlier periods, followed by declines in recent years.
*   **MDD:** Maximum Drawdown is consistently high, indicating significant risk.
*   **Alpha:** Alpha has turned negative in recent periods, meaning UNH is underperforming its benchmark on a risk-adjusted basis.
*   **Beta:** Beta fluctuates, suggesting varying degrees of correlation with the market. High Beta values (1.5) in some years indicate higher market sensitivity.
*   **Cap:** Market capitalization has fluctuated, reflecting market sentiment.

### 2. Recent Stock Price Movement

*   **Current Price:** 365.37
*   **Last Market Data:** Price 361.49, Previous Close 365.37, Change: -1.06
*   **5-Day Moving Average:** 360.85
*   **20-Day Moving Average:** 356.05
*   **60-Day Moving Average:** 318.77

**Analysis:** The stock price has shown a slight downward trend recently. The current price is below the previous close, and while it's above the 5-day and 20-day moving averages, it's showing a dip. The price is significantly above the 60-day moving average, which could indicate a longer-term upward trend, but the recent decline warrants attention. The Last Market Data shows a small price drop of -1.06, indicating a minor fluctuation.

### 3. Technical Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 64.26
*   **PPO:** -0.36
*   **Hybrid Signal:** cash_79%_Sell 79.7% of holdings (243 shares - Risky - MRI:0.50) (Cash Ratio: 79% on 2025-10-16)
*   **Recent (20-day) Relative Divergence Change:** -1.9 (Short-term decline)
*   **Expected Return:** -135.0% (Long-term, relative to S&P 500)

**Analysis:**

*   The MRI suggests that UNH is a generally good investment, but the Hybrid signal indicating a "Sell" recommendation, with high cash holdings, suggests caution due to the recent drop in relative divergence.
*   The RSI of 64.26 indicates that the stock is approaching overbought territory, but is not there yet.
*   The PPO of -0.36 is slightly negative, suggesting a mild downward trend in momentum.
*   The significant negative expected return (-135.0%) indicates that, based on current trends, UNH is expected to underperform the S&P 500 significantly over the long term.
*   The drop in price and the 'Sell' signal indicate recent volatility.

### 4. Recent News & Significant Events

*   **Bull Case Theory (Insider Monkey):** Suggests potential upside for UNH.
*   **UNH vs. HUM Comparison (Zacks):**  Compares UNH to Humana, potentially highlighting strengths and weaknesses.
*   **Valuation Assessment (Simply Wall St.):** Examines UNH's valuation, particularly in anticipation of Q3 earnings and a 2026 recovery roadmap.
*   **AI-Powered Push (Simply Wall St.):** Focuses on UNH's use of AI and its impact on the investment narrative.
*   **October 28 Calendar Reminder (Barchart):** Points to an upcoming event or announcement (likely earnings).
*   **Elevance Shares (Barrons.com):** Reports on competitor Elevance's earnings and concerns about Medicaid.

**Analysis:** Recent news coverage is mixed. There's some optimism (bull case, AI initiatives), but also valuation concerns and comparisons to competitors. The upcoming earnings announcement on October 28 is a key date to watch.  The Elevance news could have implications for the entire sector.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (~1.93) based on 25 opinions.
*   **Target Price:** Average $360.84, High $440.00, Low $198.00
*   **Recent Rating Changes:** Not specified

**Analysis:** Analyst consensus is generally positive (Buy), though the wide range of target prices indicates uncertainty about the stock's future performance.

### 5. Recent Earnings Analysis

| 날짜       | EPS    | 매출      |
| ---------- | ------ | --------- |
| 2025-08-11 | 3.76   | 111.62 B$ |
| 2025-05-07 | 6.9    | 109.58 B$ |
| 2024-11-04 | 6.56   | 100.82 B$ |
| 2024-08-09 | 4.58   | 98.86 B$  |
| 2025-08-11 | 4.58   | 98.86 B$  |

**Analysis:** Revenue has generally increased over the past year, but EPS has fluctuated. It could mean that the company's profitability has faced challenges, despite increasing revenues. The earnings data need to be examined in context with costs and guidance.

### 6. Financial Information

| Quarter      | Revenue   | Profit Margin |
| ------------ | --------- | ------------- |
| 2025-06-30   | $111.62B  | 17.93%        |
| 2025-03-31   | $109.58B  | 21.70%        |
| 2024-12-31   | $100.81B  | 21.14%        |
| 2024-09-30   | $100.82B  | 22.84%        |
| 2024-06-30   | $98.86B   | 22.31%        |

| Quarter      | Equity    | ROE       |
| ------------ | --------- | --------- |
| 2025-06-30   | $94.72B  | 3.60%     |
| 2025-03-31   | $95.04B  | 6.62%     |
| 2024-12-31   | $92.66B  | 5.98%     |
| 2024-09-30   | $94.53B  | 6.41%     |
| 2024-06-30   | $89.36B  | 4.72%     |

**Analysis:**

*   **Revenue:** Shows a positive trend, indicating business growth.
*   **Profit Margin:** Has decreased significantly in the most recent quarter, from 22.31% in 2024-06-30 to 17.93% in 2025-06-30, signaling potential cost management issues or pricing pressures.
*   **Equity:** Has slightly increased over the past year.
*   **ROE:** Return on Equity has decreased in the most recent quarter, from 4.72% in 2024-06-30 to 3.60% in 2025-06-30. This trend, combined with the decreasing profit margin, indicates a potential decline in profitability and efficiency.

### 7. Overall Summary

UNH has underperformed the S&P 500 significantly, with recent technical indicators and analyst opinions presenting a mixed picture. While the MRI suggests a generally favorable investment, other indicators, such as the Hybrid signal (Sell) and negative expected return, indicate caution. Revenue growth is present, but declining profit margins and ROE are concerning. Recent news highlights both positive and negative aspects, making the upcoming earnings announcement a critical event. Analyst ratings are generally positive (Buy), but target prices vary widely.

**In conclusion:** Based on the provided data, UNH appears to be facing some challenges. While there are positive aspects like revenue growth and analyst buy ratings, the significant underperformance compared to the S&P 500, declining profit margins, and negative expected return suggest investors should exercise caution and carefully consider the company's future prospects before investing. The upcoming earnings report will be crucial in determining whether UNH can turn things around.
